Search - tctmd.com

Displaying 321 - 340 of 367

Sort: Relevancy | Date

News Conference News TCT 2013

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

October 30, 2013

Presentation TCT 2013

Possible Solutions

Presenter: Samir Kapadia

October 29, 2013

Presentation TCT 2013

How Important Is Paravalvular Leak After TAVR and Will This Limit Its Penetration?

Presenter: Samir Kapadia

October 29, 2013

Presentation TCT 2013

Essential TAVR Technique: From Patient Selection and Workup to Access Routes to Indispensable Tips and Trick

Presenter: Samir Kapadia

October 29, 2013

Presentation TCT 2013

Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR

Presenter: Samir Kapadia

October 28, 2013

Presentation TCT 2013

Early and Late Outcomes After MitraClip in Functional MR: EVEREST Data

Presenter: Samir Kapadia

October 28, 2013

Presentation TCT 2013

Treatment of Paravalvular Leak: Percutaneous Plugging vs. Reoperation

Presenter: Samir Kapadia

October 27, 2013

Presentation TCT 2013

LAA Closure in Valvular Atrial Fibrillation (and TAVR Patients): Rationale and Results

Presenter: Samir Kapadia

October 27, 2013

Presentation TVT 2013

Transseptal Closure of Mitral Paravalvular Leaks (Including Case Presentations)

Presenter: Samir Kapadia

June 13, 2013

Presentation TVT 2013

Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR: A Recent Meta-Analysis

Presenter: Samir Kapadia

June 13, 2013

Presentation TVT 2013

Stroke Frequency and Timing after TAVR: Evolving Insights from the PARTNER Database

Presenter: Samir Kapadia

June 12, 2013

Presentation TVT 2013

Incidence, Timing, and Insights

Presenter: Samir Kapadia

June 12, 2013

News Daily News

Un Meta Análisis Analiza la Regurgitación Post-TAVR y su Influencia sobre la Mortalidad

April 12, 2013

News Daily News

Meta-analysis Looks at Post-TAVR Regurgitation, Influence on Mortality

April 12, 2013

Presentation TCT 2013

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Presenter: Sachin Goel, Wael El-Mallah, Mobolaji Ige, Supriya Gupta, E Murat Tuzcu, Stephen Ellis, Samir Kapadia

January 31, 2013

Presentation TCT 2012

Minimizing Stroke During TAVR

Presenter: Samir Kapadia

October 26, 2012

Presentation TCT 2012

Patient Selection for TAVR: Which Patients Should and Should Not Undergo a TAVR Procedure?

Presenter: Samir Kapadia

October 24, 2012

Presentation TCT 2012

A Retrospective Analysis of a Decade of (Mostly) Failed Device Approaches for Mitral Regurgitation (MR): Why Has Progress Been So Agonizingly Slow?

Presenter: Samir Kapadia

October 24, 2012

Presentation TCT 2012

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Presenter: Samir Kapadia

October 24, 2012

Presentation TCT 2012

PARTNER Cohort B Three Year: Clinical and Echocardiographic Outcomes from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement in “Inoperable” Patients

Presenter: Samir Kapadia

October 24, 2012

Advertisement

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

Possible Solutions

How Important Is Paravalvular Leak After TAVR and Will This Limit Its Penetration?

Essential TAVR Technique: From Patient Selection and Workup to Access Routes to Indispensable Tips and Trick

Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR

Early and Late Outcomes After MitraClip in Functional MR: EVEREST Data

Treatment of Paravalvular Leak: Percutaneous Plugging vs. Reoperation

LAA Closure in Valvular Atrial Fibrillation (and TAVR Patients): Rationale and Results

Transseptal Closure of Mitral Paravalvular Leaks (Including Case Presentations)

Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR: A Recent Meta-Analysis

Stroke Frequency and Timing after TAVR: Evolving Insights from the PARTNER Database

Incidence, Timing, and Insights

Un Meta Análisis Analiza la Regurgitación Post-TAVR y su Influencia sobre la Mortalidad

Meta-analysis Looks at Post-TAVR Regurgitation, Influence on Mortality

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Minimizing Stroke During TAVR

Patient Selection for TAVR: Which Patients Should and Should Not Undergo a TAVR Procedure?

A Retrospective Analysis of a Decade of (Mostly) Failed Device Approaches for Mitral Regurgitation (MR): Why Has Progress Been So Agonizingly Slow?

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

PARTNER Cohort B Three Year: Clinical and Echocardiographic Outcomes from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement in “Inoperable” Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content